Janssen Inc. et al. v. Hospira Healthcare Corporation re: REMICADE®

Represented Janssen Inc. and the Kennedy Trust in a patent impeachment and infringement action relating to REMICADE® (infliximab), a biologic treatment for rheumatoid arthritis. This was the first patent infringement action in Canada relating to a subsequent entry biologic.